Usman Azam - 29 Sep 2025 Form 3 Insider Report for Cue Biopharma, Inc. (CUE)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Usman Azam by Michael Meluzio, attorney-in-fact
Issuer symbol
CUE
Transactions as of
29 Sep 2025
Net transactions value
$0
Form type
3
Filing time
02 Oct 2025, 20:13:09 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Azam Usman CHIEF EXECUTIVE OFFICER, Director C/O CUE BIOPHARMA, INC., 40 GUEST STREET, BOSTON /s/ Usman Azam by Michael Meluzio, attorney-in-fact 02 Oct 2025 0002089768

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney